Interview of Sergio Marullo di Condojanni with AffarItaliani at WOBI 2024

I'd highlight two key aspects. First of all, innovation begins with implementing modern processes that facilitate effective decision-making within the organization. We have established several policies and governance structures that allow us to be agile and highly efficient in our decision-making. Second, from a business standpoint, mental health is a pressing need today. As a well-recognized player in this field, we are dedicated to developing new treatments to address needs that, unfortunately, are expected to grow.

As mentioned earlier, we can expect a significant focus on mental health, especially given the increasing need among young people and adolescents. At the same time, we will prioritize the renewal and ongoing innovation of our traditional business operations.

The United States remains the world's leading market in pharmaceuticals and other sectors because it actively encourages and promotes innovation. In contrast, Europe needs to undertake a thorough review of its approach to healthcare, particularly in terms of mental health, as it has been less attentive to fostering innovation in recent years. Therefore, strengths lie in benchmarking the U.S. market, while Europe is our home, and we want to stay and invest here. However, it is equally essential that the environment becomes more conducive to growth.